Association of TP53 mutations with TP53 codon 72 polymorphism and outcome in triple-negative breast cancer
暂无分享,去创建一个
M. Gnant | M. Preusser | P. Dubsky | G. Steger | R. Bartsch | C. Zielinski | M. Rudas | O. Zach | A. Weltermann | A. Berghoff | R. Promberger | Mathilde Foedermayr | Miriam Sebesta
[1] M. Gnant,et al. BRCA-1 methylation and TP53 mutation in triple-negative breast cancer patients without pathological complete response to taxane-based neoadjuvant chemotherapy , 2014, Cancer Chemotherapy and Pharmacology.
[2] M. Schreiber,et al. The Pro Allele of the p53 Codon 72 Polymorphism Is Associated with Decreased Intratumoral Expression of BAX and p21, and Increased Breast Cancer Risk , 2012, PloS one.
[3] D. Walerych,et al. The rebel angel: mutant p53 as the driving oncogene in breast cancer , 2012, Carcinogenesis.
[4] Wei Gu,et al. Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.
[5] A. Goldhirsch,et al. The triple-negative subtype: new ideas for the poorest prognosis breast cancer. , 2011, Journal of the National Cancer Institute. Monographs.
[6] W. Wang,et al. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case–control study , 2011, Breast Cancer Research and Treatment.
[7] Varda Rotter,et al. Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. , 2011, Genes & cancer.
[8] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[9] Magali Olivier,et al. TP53 mutations in human cancers: origins, consequences, and clinical use. , 2010, Cold Spring Harbor perspectives in biology.
[10] Y. Miyagi,et al. Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy , 2009, BMC Cancer.
[11] L. Cai,et al. Polymorphisms of TP53 codon 72 with breast carcinoma risk: evidence from 12226 cases and 10782 controls , 2009, Journal of experimental & clinical cancer research : CR.
[12] S. Wingren,et al. Biological significance of allele specific loss of the p53 gene in breast carcinomas , 2009, Breast Cancer Research and Treatment.
[13] A. Rosenberg,et al. Differences in breast carcinoma characteristics in newly diagnosed African–American and Caucasian patients , 2007, Cancer.
[14] M. Olivier,et al. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database , 2007, Human mutation.
[15] J. Jónasson,et al. Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer , 2006, Breast Cancer Research.
[16] C. Perou,et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.
[17] J. Bergh,et al. The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] M. Stratton,et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website , 2004, British Journal of Cancer.
[19] T. Crook,et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo , 2004, Oncogene.
[20] M. Murphy,et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential , 2003, Nature Genetics.
[21] P. Lønning,et al. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[22] J. Godbold,et al. Polymorphisms of H-ras-1 and p53 in breast cancer and lung cancer: a meta-analysis. , 1997, Environmental health perspectives.
[23] G. Hallmans,et al. p53 polymorphisms and haplotypes in breast cancer. , 1996, Carcinogenesis.
[24] R. Birgander,et al. p53 polymorphisms and haplotypes in different ethnic groups. , 1995, Human heredity.
[25] R. Birgander,et al. Is p53 polymorphism maintained by natural selection? , 1994, Human heredity.
[26] J. Simon,et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[27] D. Lane,et al. p53: oncogene or anti-oncogene? , 1990, Genes & development.